View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Pharmatest
29 August 2017

Pharmatest Services Arranges Educational Seminar

Pharmatest has announced an upcoming seminar at the Boston Marriott hotel in Copley Place.

Titled ‘Significance of Bone Metastases and Targeting Tumor, Bone and Immune System’, the seminar will take place on 6 September from 8.00 am to 10.30 am.

Many oncology drugs still fail in clinical trials due to poor efficacy. One important reason for this is that compound efficacy is not confirmed in clinically relevant preclinical metastasis models before entering clinical trials. This would be important because the metastatic microenvironment changes tumour properties and induces drug resistance.

This educational seminar highlights significance of bone metastases in clinical and preclinical aspects. Keynote speaker of the seminar will be Dr. Matthew Smith from Massachusetts General Hospital Cancer Center, and other speakers will be from MassBio, Taconic Biosciences, and Pharmatest.

CEO of Pharmatest Jussi Halleen comments: "It is our mission to decrease the currently very high failure rates of oncology drugs in clinical trials, and we want to emphasise the importance of confirming compound efficacy in preclinical metastasis models to achieve this goal".

Pharmatest welcomes everyone to join this educational seminar. The company offers preclinical efficacy services for the pharmaceutical industry in the fields of oncology and skeletal diseases. In oncology Pharmatest has been the leading provider of bone metastasis models since 2005.

4T1 is a triple-negative mouse breast cancer cell line. Pharmatest utilises a 4T1 cell line with stable expression of green fluorescent protein (GFP) enabling easy...
Metastatic and primary tumours are known to respond differently to chemotherapy. Therefore, when establishing drug efficacy it is important not to rely only on experiments...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology